22 June 2011: On 24 May 2011, NorDiag announced that the company had entered into an agreement to sell all of its shares in Olerup International AB to LinkMed AB for a cash consideration of SEK 8 million. The transaction included Olerup International's wholly-owned subsidiary Olerup GmbH (Austria). In compliance with section 3.5 of the Oslo Stock Exchange's Continuing obligations of stock exchange listed companies, an information memorandum in respect of the transaction is attached.

Contact:
CFO Tone Kvåle                 Phone: +47 915 19576
 
About NorDiag:
NorDiag is a biotechnology company developing, manufacturing and marketing automated solutions (instruments and reagents) for sample preparation of DNA from difficult biological samples. DNA diagnostics give more rapid and precise answers, and are the fastest growing field within diagnostics. The Company's sample preparation solutions are today used in connection with STI, tuberculosis, MRSA, respiratory pathogens and viruses on instruments for large and small laboratories. NorDiag was founded in 2003 and has its headquarters in Oslo, Norway. The Company has offices and laboratories in Stockholm, Sweden and in Atlanta (GA), USA. The group has today 34.3 man-labour years. NorDiag is listed on the Oslo Stock Exchange with ticker NORD.
 
For further information - www.nordiag.com

Find the information memorandum here

Read the notice in Norwegian here